FDA Clearance Tracker · P040044-S068
MYNXGRIP VASCULAR CLOSURE DEVICE (5F, 6F/7F)
Last checked: Nov 20, 2026Latest source record: Sep 6, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Sep 6, 2016
Approved
Time to decision
274 days
Received Dec 7, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040044-S068
- Device name
- MYNXGRIP VASCULAR CLOSURE DEVICE (5F, 6F/7F)
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- Dec 7, 2015
- Decided
- Sep 6, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at 9020 Activity Road, Suite D, San Diego, California, 92126 for the sterilization of the Mynx Grip Vascular Closure Device (5F/6F/7F) and Mynx Ace Vascular Closure Device (5F/6F/7F).
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.